Minoxidil for Hair Loss: Who Can Use It?

What is the difference between topical and oral minoxidil?

Topical minoxidil is applied directly to the scalp and is one of the approved treatments for androgenetic alopecia. Low-dose oral minoxidil is increasingly used for hair loss, but it is used off-label.

How does minoxidil work?

It can help prolong the growth phase of the hair follicle, thicken some miniaturized hairs, and maintain hair density. It does not create new hair follicles.

Is it used for male and female pattern hair loss?

Yes. It is an important treatment option for androgenetic alopecia in both men and women. In women, concomitant causes such as iron deficiency, thyroid disorders, telogen effluvium, or hyperandrogenism should also be investigated as needed.

Is oral minoxidil more effective than topical minoxidil?

Meta-analyses of current randomized trials have not demonstrated a clear efficacy superiority of oral minoxidil over the topical form. The oral form may be considered in selected patients who cannot tolerate the topical form or have poor adherence to daily application.

What are the side effects of oral minoxidil?

The most common side effect is increased unwanted hair growth. Possible side effects include edema, dizziness, palpitations, headache, and low blood pressure. Because it is a systemic medication, cardiovascular history and other medications should be considered.

Could hair loss increase initially?

Some patients may experience temporary, initial hair loss in the first few weeks. Not all severe hair loss should be automatically attributed to minoxidil.

When will the effects be seen?

Because the hair growth cycle is slow, several months of regular use are required. Standard photography and trichoscopy can provide objective monitoring.

What happens if it's left alone?

Androgenetic alopecia is chronic. Some of the hair protected by minoxidil may be lost over time when treatment is discontinued.

Can telogen be used in effluvium?

Treatment is not the standard or mandatory treatment for acute telogen effluvium. The priority is to identify and correct the trigger. In chronic cases, it may be considered in selected patients; the evidence is not as strong as in androgenetic alopecia.

Is it used for alopecia areata?

It does not treat the underlying immunological mechanism of the disease; it may be an adjunct therapy in some patients.

Is it used in scarring alopecia?

It is not a substitute for stopping active inflammation. Once a follicle has been permanently scarred, minoxidil will not stimulate new hair growth from that follicle.

The decision to use minoxidil should be made after a diagnosis of hair loss. While it is a strong option in androgenetic alopecia, it does not play the same role in acute telogen effluvium or scarring alopecia; the choice between topical and oral forms should be based on safety and compliance as well as efficacy.

Dermatologist's Perspective